Phase III Trial Shows Personalized Melanoma Vaccine Improves Outcomes
A phase III clinical trial showed that a personalized melanoma vaccine, when combined with immunotherapy, improves patient outcomes. The study, which followed 1,137 patients with resected stage IIB to IV … Read More